Our Strategies

Psychedelic Production

We are developing industrial-scale production of pharmaceutical-grade psychedelic compounds, including psilocybin and mescaline. Our hope is to support further research into their potential as treatment options for mental health-related medical conditions.

Drug Formulations

We are focused on applying XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to emerging APIs. This has the potential to create standardized drug formulations with safe and precise dosing for clinical study and therapeutic use.

Clinical Validation

We are planning clinical programs to test and validate our psychedelic drug formulations in the treatment of addiction and depression. Stay tuned for further developments.

Psilocybin API Production

New opportunities for psychedelic compounds

Our research and development in psychedelic treatments with modern scientific methods and validation has the potential to change the narrative on mental health-related medical conditions.

Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.